Provided by Tiger Trade Technology Pte. Ltd.

Tectonic Therapeutic, Inc.

23.04
+1.697.92%
Volume:334.43K
Turnover:7.22M
Market Cap:431.22M
PE:-5.94
High:23.26
Open:21.34
Low:21.00
Close:21.35
52wk High:27.64
52wk Low:13.70
Shares:18.72M
Float Shares:9.74M
Volume Ratio:1.63
T/O Rate:3.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8785
EPS(LYR):-6.8293
ROE:-32.21%
ROA:-21.46%
PB:1.61
PE(LYR):-3.37

Loading ...

Company Profile

Company Name:
Tectonic Therapeutic, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
51
Office Location:
490 Arsenal Way,Suite 210,Watertown,Massachusetts,United States
Zip Code:
02472
Fax:
- -
Introduction:
Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts.

Directors

Name
Position
Alise Reicin
Director,President and Chief Executive Officer
François Nader
Chair of the Board
Phillip Donenberg
Independent Director
Praveen Tipirneni
Independent Director
Stefan Vitorovic
Independent Director
Timothy A. Springer
Independent Director

Shareholders

Name
Position
Alise Reicin
Director,President and Chief Executive Officer
Daniel Lochner
Chief Financial Officer
Marc Schwabish
Chief Business Officer
Marcella K. Ruddy
Chief Medical Officer
Peter McNamara
Chief Scientific Officer